Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-008497
Filing Date
2023-05-22
Accepted
2023-05-22 16:20:29
Documents
1
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 form4-05222023_040518.html 4  
1 form4-05222023_040518.xml 4 3966
  Complete submission text file 0001415889-23-008497.txt   5332
Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Patel Kavita (Reporting) CIK: 0001670683 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 23944698

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations